Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein.
|
J Virol
|
1983
|
3.30
|
2
|
Evidence for the direct involvement of the rhinovirus canyon in receptor binding.
|
Proc Natl Acad Sci U S A
|
1988
|
3.29
|
3
|
Gene structure of human cardiac hormone precursor, pronatriodilatin.
|
Nature
|
1985
|
2.41
|
4
|
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
|
Proc Natl Acad Sci U S A
|
1990
|
2.32
|
5
|
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.
|
Antimicrob Agents Chemother
|
1993
|
2.10
|
6
|
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
|
J Biol Chem
|
1992
|
2.04
|
7
|
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
|
Ann Intern Med
|
2000
|
1.88
|
8
|
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
|
JAMA
|
1998
|
1.59
|
9
|
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
|
J Med Chem
|
1993
|
1.54
|
10
|
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors.
|
Antimicrob Agents Chemother
|
1994
|
1.53
|
11
|
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site.
|
Biochemistry
|
1994
|
1.42
|
12
|
HIV and multidrug resistance.
|
Nature
|
1993
|
1.31
|
13
|
Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors.
|
Proc Natl Acad Sci U S A
|
1984
|
1.26
|
14
|
Replicative RNA synthesis and nucleocapsid assembly in vesicular stomatitis virus-infected permeable cells.
|
J Virol
|
1980
|
1.10
|
15
|
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333.
|
J Infect Dis
|
2000
|
1.04
|
16
|
Avian cells expressing the murine Mx1 protein are resistant to influenza virus infection.
|
Virology
|
1991
|
0.99
|
17
|
Parental influenza virion nucleocapsids are efficiently transported into the nuclei of murine cells expressing the nuclear interferon-induced Mx protein.
|
J Virol
|
1990
|
0.96
|
18
|
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
|
J Biol Chem
|
1993
|
0.94
|
19
|
Resisting resistance: maximizing the durability of antiretroviral therapy.
|
Ann Intern Med
|
1998
|
0.92
|
20
|
Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy.
|
AIDS Res Hum Retroviruses
|
1999
|
0.90
|
21
|
Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits.
|
Protein Expr Purif
|
1994
|
0.88
|
22
|
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.
|
Arch Virol Suppl
|
1994
|
0.81
|
23
|
High-level expression in Escherichia coli of a chemically synthesized gene for [Leu-28]echistatin.
|
Gene
|
1989
|
0.81
|
24
|
In vivo selection of HIV-1 variants with reduced susceptibility to the protease inhibitor L-735,524 and related compounds.
|
Adv Exp Med Biol
|
1996
|
0.80
|
25
|
A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
|
Antimicrob Agents Chemother
|
1993
|
0.80
|
26
|
Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus.
|
Gene
|
1987
|
0.78
|
27
|
Genotypic analysis methods for detection of drug resistance mutations in the HIV-1 proteinase and reverse transcriptase genes.
|
Antivir Ther
|
1999
|
0.78
|
28
|
Induction of the SOS system by DNA ligase-deficient growth of Escherichia coli.
|
J Gen Microbiol
|
1982
|
0.76
|